Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -365.62%-20.91M | ---- | 121.26%7.87M | ---- | -1,042.73%-37.04M | ---- | -55.02%3.93M | ---- | 119.54%8.74M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -892.31%-129K | ---- | 80.30%-13K | ---- | -725.00%-66K | ---- | ---8K | ---- | ---- |
| Impairment and provisions: | ---- | 6,446.45%9.84M | ---- | -102.28%-155K | ---- | 104.54%6.8M | ---- | 123.85%3.32M | ---- | -190.28%-13.94M |
| -Impairment of property, plant and equipment (reversal) | ---- | --67K | ---- | ---- | ---- | -30.68%1.19M | ---- | --1.71M | ---- | ---- |
| -Impairment of trade receivables (reversal) | ---- | 18.23%467K | ---- | --395K | ---- | ---- | ---- | --1.94M | ---- | ---- |
| -Impairment of goodwill | ---- | --9M | ---- | ---- | ---- | ---- | ---- | --92K | ---- | ---- |
| -Other impairments and provisions | ---- | 155.09%303K | ---- | -109.80%-550K | ---- | 1,432.78%5.61M | ---- | 96.98%-421K | ---- | -203.15%-13.94M |
| Revaluation surplus: | ---- | 99.99%-2K | ---- | -672.76%-13.88M | ---- | 151.88%2.42M | ---- | ---4.67M | ---- | ---- |
| -Other fair value changes | ---- | 99.99%-2K | ---- | -672.76%-13.88M | ---- | 151.88%2.42M | ---- | ---4.67M | ---- | ---- |
| Asset sale loss (gain): | ---- | 1,059.38%1.86M | ---- | 106.59%160K | ---- | 85.59%-2.43M | ---- | -1,441.45%-16.86M | ---- | -74.26%1.26M |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | 63.78%-1.38M | ---- | -787.41%-3.81M | ---- | ---429K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -103.13%-5K | ---- | 115.24%160K | ---- | ---1.05M | ---- | ---- | ---- | ---- |
| -Loss (gain) from selling other assets | ---- | --1.86M | ---- | ---- | ---- | ---- | ---- | -874.32%-13.06M | ---- | --1.69M |
| Depreciation and amortization: | ---- | -12.50%10.63M | ---- | -2.43%12.14M | ---- | -17.28%12.45M | ---- | -39.04%15.05M | ---- | 36,195.59%24.68M |
| -Amortization of intangible assets | ---- | 0.00%2.12M | ---- | 1,097.74%2.12M | ---- | --177K | ---- | ---- | ---- | ---- |
| Financial expense | ---- | -13.15%925K | ---- | 34.64%1.07M | ---- | -26.76%791K | ---- | -52.53%1.08M | ---- | -26.54%2.28M |
| Special items | ---- | -124.39%-10K | ---- | -99.55%41K | ---- | 953.32%9.12M | ---- | 77.69%-1.07M | ---- | -114.68%-4.79M |
| Operating profit before the change of operating capital | ---- | -69.74%2.19M | ---- | 190.96%7.24M | ---- | -1,134.59%-7.96M | ---- | -95.78%769K | ---- | 59.98%18.22M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 1,900.96%1.87M | ---- | 86.02%-104K | ---- | -765.12%-744K | ---- | 48.50%-86K | ---- | 69.36%-167K |
| Accounts receivable (increase)decrease | ---- | -823.55%-13.36M | ---- | -77.45%1.85M | ---- | 221.32%8.19M | ---- | -97.28%-6.75M | ---- | -187.41%-3.42M |
| Accounts payable increase (decrease) | ---- | 4,417.59%22.86M | ---- | -92.71%506K | ---- | 2,416.30%6.95M | ---- | 105.27%276K | ---- | -1,137.82%-5.24M |
| Financial assets at fair value (increase)decrease | ---- | ---- | ---- | ---255K | ---- | ---- | ---- | ---- | ---- | ---- |
| Special items for working capital changes | ---- | 90.91%42K | ---- | 101.23%22K | ---- | -126.26%-1.78M | ---- | 5,953.45%6.79M | ---- | 72.77%-116K |
| Cash from business operations | ---- | 46.98%13.6M | ---- | 98.90%9.25M | ---- | 366.13%4.65M | ---- | -89.24%998K | ---- | -37.49%9.28M |
| Other taxs | ---- | -659.50%-919K | ---- | ---121K | ---- | ---- | ---- | -79.22%16K | ---- | -84.19%77K |
| Special items of business | 15.42%11.25M | ---- | 90.22%9.75M | ---- | 6.13%5.12M | ---- | 63.46%4.83M | ---- | -76.79%2.95M | ---- |
| Net cash from operations | 15.42%11.25M | 38.86%12.68M | 90.22%9.75M | 96.30%9.13M | 6.13%5.12M | 358.78%4.65M | 63.46%4.83M | -89.16%1.01M | -76.79%2.95M | -35.86%9.35M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | 892.31%129K | ---- | -80.30%13K | ---- | 725.00%66K | ---- | --8K | ---- | ---- |
| Loan receivable (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 1,363.05%15.01M |
| Sale of fixed assets | ---- | -95.05%60K | ---- | -40.34%1.21M | ---- | --2.03M | ---- | ---- | ---- | ---- |
| Purchase of fixed assets | ---- | -252.23%-11.75M | ---- | -15,790.48%-3.34M | ---- | 55.32%-21K | ---- | 79.65%-47K | ---- | 96.21%-231K |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | -100.03%-1K | ---- | 17,252.38%3.6M | ---- | ---21K |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | -2,088.12%-9.21M | ---- | --463K | ---- | ---- |
| Recovery of cash from investments | ---- | --680K | ---- | ---- | ---- | ---- | ---- | --41.59M | ---- | ---- |
| Other items in the investment business | -1.24%-4.32M | ---- | 46.25%-4.27M | ---- | -4,926.58%-7.94M | ---1.18M | -100.36%-158K | ---- | --43.85M | ---- |
| Net cash from investment operations | -1.24%-4.32M | -415.14%-10.89M | 46.25%-4.27M | 74.56%-2.11M | -4,926.58%-7.94M | -118.21%-8.31M | -100.36%-158K | 209.21%45.62M | 1,544.60%43.85M | 171.00%14.75M |
| Net cash before financing | 26.48%6.93M | -74.41%1.8M | 294.25%5.48M | 292.04%7.02M | -160.38%-2.82M | -107.84%-3.66M | -90.02%4.67M | 93.45%46.63M | 204.14%46.8M | 488.93%24.11M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | 87.35%4M | ---- | --2.14M | ---- | ---- | ---- | ---- | ---- | ---- |
| Refund | ---- | -86.40%-4.03M | ---- | -214.56%-2.16M | ---- | 95.42%-687K | ---- | -156.10%-15M | ---- | ---5.86M |
| Issuing shares | ---- | --3.91M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --8.32M |
| Interest paid - financing | ---- | 46.42%-427K | ---- | -5.01%-797K | ---- | 29.72%-759K | ---- | 52.53%-1.08M | ---- | 3.31%-2.28M |
| Dividends paid - financing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 76.60%-88K |
| Other items of the financing business | -276.69%-4.75M | ---- | 57.30%-1.26M | ---- | 38.38%-2.95M | ---- | 78.01%-4.79M | ---- | ---21.8M | ---- |
| Net cash from financing operations | -276.69%-4.75M | 74.33%-3.6M | 57.30%-1.26M | -10.37%-14.02M | 38.38%-2.95M | 53.94%-12.7M | 78.01%-4.79M | -93.02%-27.57M | -44.93%-21.8M | -12.94%-14.28M |
| Effect of rate | ---- | ---- | ---- | ---- | ---- | -188.89%-24K | -14,235.29%-2.44M | --27K | ---17K | ---- |
| Net Cash | -48.37%2.18M | 74.24%-1.8M | 173.02%4.22M | 57.22%-7M | -4,592.68%-5.77M | -185.77%-16.35M | -100.49%-123K | 94.07%19.07M | 7,064.18%25M | 152.13%9.82M |
| Begining period cash | -21.13%6.73M | -45.06%8.53M | -45.06%8.53M | -51.33%15.53M | -51.33%15.53M | 149.03%31.9M | 149.03%31.9M | 328.89%12.81M | 328.89%12.81M | -86.32%2.99M |
| Cash at the end | -30.14%8.9M | -21.13%6.73M | 30.66%12.75M | -45.06%8.53M | -66.76%9.75M | -51.33%15.53M | -22.37%29.34M | 149.03%31.9M | 1,033.00%37.8M | 328.89%12.81M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Fan Chen Accounting Firm Limited | -- | Fan Chen Accounting Firm Limited | -- | Fan Chen Accounting Firm Limited | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | Kaiyuan Shun Tak Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.